Cross-Border Litigation Strategy for US Tech Companies: Using Global Forums to Drive Leverage and Resolution

For US-based in-house teams, patent disputes are increasingly shaped by what happens in key jurisdictions abroad. Actions in the UPC, the UK, and China are now being used deliberately to influence injunction risk, royalty negotiations, and settlement outcomes in US-led disputes. For MedTech companies, cross-border disputes often intersect with regulatory approvals and global device supply chains, adding additional strategic considerations. This session focuses on how US legal teams and their counsel are integrating global forums into their overall litigation and licensing strategy.

• When and where to consider cross-border litigation in tech patent cases.
• How US-based teams are using UPC litigation in cases such as ParTec v. NVIDIA to create early leverage and pressure global settlement.
• When injunction risk in Europe meaningfully alters the US damages-focused analysis, and how US teams factor in that risk.
• How court-led rate setting in the UK (global FRAND determinations) and China (manufacturing and sales-based jurisdictional leverage) is used by US companies to narrow valuation gaps and restart stalled negotiations.